Covaxin trial participant’s death unrelated to ‘vaccine or placebo’: Bharat Biotech
He was reported to be healthy in follow-up calls post seven days of his dosing and no adverse reaction was observed or reported,…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.